Deep search
All
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Search
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA Approves 1st Non-Opioid Pain Drug in 20 Years
FDA approves new pain medication as an alternative to opioids: What to know about Journavx
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.
FDA OK's painkiller designed to end opioids' addiction and overdose risk
Federal officials approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin.
What is Non-Opioid Pain Medication? Journavx Approved by FDA
The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.
Axsome, FDA and migraine
US FDA approves Axsome Therapeutics' migraine drug
The U.S. Food and Drug Administration has approved Axsome Therapeutics' migraine treatment, the company said on Thursday.
Axsome Therapeutics announces FDA approval of Symbravo
Axsome Therapeutics (AXSM) announced that the U.S. FDA has approved Symbravo for the acute treatment of migraine with or without aura in
Axsome gets FDA approval for Symbravo for migraine
Axsome Therapeutics (NASDAQ:AXSM) has received FDA approval for its drug Symbravo for the acute treatment of migraine with or without aura in adults. Symbravo, a combination of meloxicam and rizatriptan,
FDA upgrades recall of Lay's potato chips
Lay's potato chips recall upgraded to FDA's most serious level. Is Ohio affected?
The FDA elevated Lay's Classic Potato Chips to the highest risk level. Here what to know, and whether the recall impacts Ohio.
FDA reclassifies Lay’s potato chips recall to the highest risk level, warning the chips could cause ‘serious adverse health consequences or death’
The FDA has raised the risk level on a recall of Lay’s potato chips to the highest level, warning the recalled product could cause death. The chips were originally recalled last month for containing undeclared milk.
Lay’s Potato Chip Recall Increased to Highest Risk Level, FDA Warns Product Could Cause 'Death’
Lay’s Classic Potato Chips due to “undeclared milk.” The affected chips were sold in Oregon and Washington. On Monday, Jan. 27, the FDA classified the issue as a Class 1 recall, which is defined as “a situation in which there is a reasonable probability that the use of,
2d
on MSN
FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients
Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...
19h
Walmart's Broccoli Recall Now Classified As Potentially Deadly, According To The FDA
In early January it was revealed that Walmart's washed and ready-to-eat 12 oz. Marketside Broccoli Florets were voluntarily ...
2d
on MSN
Chocolate Recall Update As FDA Sets Highest Risk Level for 9 States
A recall which was issued across nine states has now been given the highest risk classification by the federal agency.
Opinion
19h
Opinion
Do food warning labels actually work? Answering your questions.
Readers had a lot to say about my latest column on the Food and Drug Administration’s proposed front-of-package labels. Most ...
1d
FDA Recalls Blood Pressure Drug Over ‘Visible Black’ Contaminants
Medicine may not be an exact science, but precision is crucial for patient care. That’s why the presence of unknown particles ...
1h
2025 Medical Device Cybersecurity Trends: What Will Shape The Industry?
What will the industry face or achieve in 2025? These trends will be critical in medical device cybersecurity.
2h
Chocolate Recalled in 3 States Over Possible 'Life-Threatening' Reaction
A chocolate-covered pretzel product is being recalled in three states due to the presence of an undeclared milk allergen.
29m
Sun Pharma Q3FY25 results: Net profit soars 15%, revenue up 10.5%
Domestic formulation sales increased by 13.8 per cent to Rs 4,300.4 crore Y-o-Y, representing 32 per cent of the company's ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Popular topics
# FDA
Related topics
FDA
recall
Journavx
Vertex Pharmaceuticals
Frito-Lay
Feedback